ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine

We hypothesized that circulating tumor DNA (ctDNA) molecular residual disease (MRD) analysis without prior mutational knowledge could be performed after neoadjuvant chemotherapy to assess oligometastatic colorectal cancer (CRC) treated surgically with curative intent. We also investigated urine as a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCO Precis Oncol
Autors principals: Pellini, Bruna, Pejovic, Nadja, Feng, Wenjia, Earland, Noah, Harris, Peter K., Usmani, Abul, Szymanski, Jeffrey J., Qaium, Faridi, Mudd, Jacqueline, Petty, Marvin, Jiang, Yuqiu, Singh, Ashla, Maher, Christopher A., Henke, Lauren E., Park, Haeseong, Ciorba, Matthew A., Kim, Hyun, Mutch, Matthew G., Pedersen, Katrina S., Tan, Benjamin R., Hawkins, William G., Fields, Ryan C., Chaudhuri, Aadel A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2021
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8232837/
https://ncbi.nlm.nih.gov/pubmed/34250420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00276
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars